Non‐canonical functions of the tuberous sclerosis complex‐Rheb signalling axis
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The protein products of the tuberous sclerosis complex ( TSC ) genes, TSC1 and TSC2, form a complex, which inhibits the small G‐protein, Ras homolog enriched in brain (Rheb). The vast majority of research regarding these proteins has focused on mammalian Target of Rapamycin (mTOR), a target of Rheb. Here, we propose that there are clinically relevant functions and targets of TSC1, TSC2 and Rheb, which are independent of mTOR. We present evidence that such non‐canonical functions of the TSC‐Rheb signalling network exist, propose a standard of evidence for these non‐canonical functions, and discuss their potential clinical and therapeutic implications for patients with TSC and lymphangioleiomyomatosis (LAM).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for Autophagy
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S.-I., Natsume, T., Takehana, K., Yamada, N., et al. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1248 · Cited by 2,076
ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
Jung, C. H., Jun, C. B., Ro, S.-H., Kim, Y.-M., Otto, N. M., Cao, J., Kundu, M., & Kim, D.-H. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1249 · Cited by 2,025
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911 · cited 5×
“…tuberin, respectively), act as a heterodimer to inhibit the activity of the small GTPase Rheb through TSC2’s evolutionarily conserved GTPase activating protein (GAP) domain located near its carboxy-terminus (Inoki et al, 2003a; Plank et al, 1998; van Slegtenhorst et al, 1998; Zhang et al, 2003).”
BackgroundInfluentialLoewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886 · cited 2×
“Rheb-GTP activates the mTORC1, which consists minimally of mTOR, Raptor and mLST8 (Hara et al, 2002; Kim et al, 2002, 2003; Loewith et al, 2002).”
BackgroundThe primary cilium: a signalling centre during vertebrate development
Goetz, S. C., & Anderson, K. V. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2774 · Cited by 1,824
Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Self-citationIdentification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648 · cited 1×
“The TSC1 and TSC2 genes, which are mutated in affected individuals, were cloned in 1997 and 1993, respectively (Consortium ECTS, 1993; van Slegtenhorst et al, 1997).”
BackgroundSelf-citationIdentification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268 · cited 1×
“…two kinases (CDK1 and IKKb) directly phosphorylate TSC1; all eight have been shown to regulate the activity of TORC1 (Astrinidis et al, 2003; Catania et al, 2001; Dan et al, 2002; Inoki et al, 2006, 2003b; Lee et al, 2007b; Li et al, 2003; Ma et al, 2005; Manning et al, 2002; Roux et al, 2004).”
BackgroundHudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827 · cited 1×
“…of TSC was propelled in 2002 by the discovery that the TSC proteins inhibit the mammalian Target of Rapamycin (mTOR), a serine/ threonine protein kinase, which regulates a wealth of cellular functions including cell growth and survival (Gao et al, 2002; Jaeschke et al, 2002; Tee et al, 2002).”
BackgroundInteraction between hamartin and tuberin, the TSC1 and TSC2 gene products
van Slegtenhorst, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.6.1053 · Cited by 565
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00187-9 · Cited by 528
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L. (2005) · Nature Neuroscience · doi:10.1038/nn1566 · Cited by 497 · cited 1×
“Surprisingly, both knockdown of Tsc2 in cultured rat neurons and Rapamycin treatment of WT neurons resulted in enhanced EMBO Mol Med 3, 189–200 www.embomolmed.org dendritic spine length (Tavazoie et al, 2005).”
BackgroundCastro, A. F., Rebhun, J. F., Clark, G. J., & Quilliam, L. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300226200 · Cited by 381 · cited 1×
“…was identified as the mediator through which the TSC proteins regulate the mTOR Complex 1 (mTORC1), and the sequence of the ‘canonical’ TSC/Rheb/ mTORC1 pathway was established (Castro et al, 2003; Garami et al, 2003; Inoki et al, 2003a; Saucedo et al, 2003; Stocker et al, 2003; Zhang et al, 2003).”
BackgroundDi Nardo, A., Kramvis, I., Cho, N., Sadowski, A., Meikle, L., Kwiatkowski, D. J., & Sahin, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0778-09.2009 · Cited by 165 · cited 1×
“Several reports suggest that there are pro-apoptotic effects of Rheb activation, which are mTOR-dependent (Di Nardo et al, 2009; Freilinger et al, 2006; Inoki et al, 2003b; Kang et al, 2010; Karassek et al, 2010; Lee et al, 2007a; Ozcan et al, 2008).”
BackgroundPanepinto, J. C., Oliver, B. G., Fortwendel, J. R., Smith, D. L. H., Askew, D. S., & Rhodes, J. C. (2003) · Infection and Immunity · doi:10.1128/iai.71.5.2819-2826.2003 · Cited by 72 · cited 1×
“…pombe and Aspergillus fumigatus, activation of the Rheb homolog results in suppression of uptake of basic amino acids www.embomolmed.org EMBO Mol Med 3, 189–200 such as arginine (Matsumoto et al, 2002; Panepinto et al, 2003; Tsao et al, 2009; Urano et al, 2000; van Slegtenhorst et al, 2004).”
Background
Cited by
Yu, J. S. L., & Cui, W. (2016) · Development · doi:10.1242/dev.137075 · Cited by 1,135
Henske, E. P., Jóźwiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.35 · Cited by 831
Self-citationRegulation of innate immune cell function by mTOR
Weichhart, T., Hengstschläger, M., & Linke, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3901 · Cited by 830
Yang, K., Shrestha, S., Zeng, H., Karmaus, P. W. F., Neale, G., Vogel, P., Guertin, D. A., Lamb, R. F., & Chi, H. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.015 · Cited by 394
Molecular neurobiology of mTOR
Switon, K., Kotulska, K., Janusz-Kaminska, A., Zmorzynska, J., & Jaworski, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.017 · Cited by 387
Metadata
- Authors
- Neuman, N. A., & Henske, E. P.
- Venue
- EMBO Molecular Medicine
- Published
- 2011-03-16
- Volume
- 3
- Issue
- 4
- Pages
- 189-200
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2108714764
- Cited by
- 86
- References
- 20
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.